Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
Metformin on the Presence of COVID-19 Symptoms 6 Months after Infection: The ACTIV-6 Randomized Clinical Trial.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: April 08, 2026
Metformin on Time to Sustained Recovery in Adults with COVID-19: The ACTIV-6 Randomized Clinical Trial.
Journal: medRxiv : the preprint server for health sciences
Published: October 01, 2025
Metformin on the Presence of COVID-19 Symptoms Over 6 Months: The ACTIV-6 Randomized Clinical Trial.
Metformin on the Presence of COVID-19 Symptoms Over 6 Months: The ACTIV-6 Randomized Clinical Trial.
Journal: medRxiv : the preprint server for health sciences
Published: August 20, 2025
Metformin and Time to Sustained Recovery in Adults With COVID-19: The ACTIV-6 Randomized Clinical Trial.
Journal: JAMA internal medicine
Published: July 14, 2025
Time to Sustained Recovery Among Outpatients With COVID-19 Receiving Montelukast vs Placebo: The ACTIV-6 Randomized Clinical Trial.
Journal: JAMA network open
Published: October 18, 2024
Effect of Montelukast vs Placebo on Time to Sustained Recovery in Outpatients with COVID-19: The ACTIV-6 Randomized Clinical Trial.
Journal: medRxiv : the preprint server for health sciences
Published: May 27, 2024
Showing 1-7 of 7
Last Updated: 09/26/2026